Check how well stool DNA tests help watch for colon cancer return
Part of Cancer, Digestive system clinical trials.
This trial studies whether an at-home stool DNA test (Mt-sDNA) can safely and usefully monitor people after colon or rectal cancer treatment. It’s mainly about whether the test is practical and helpful during routine follow-up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had stage I, II, or III colon or rectal adenocarcinoma (not stage IV).
- You had a colonoscopy before surgery, and that information is available.
- You had bowel surgery (bowel resection), and you may have also had chemotherapy and/or radiation as planned.
- You do not have inflammatory bowel disease (ulcerative colitis or Crohn’s).
- Your cancer history does not include certain inherited conditions like Lynch syndrome or other polyposis syndromes.
- Any higher-risk growths (advanced adenomas) seen before surgery were removed, or were fully contained in the removed tissue.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a simple blood test to look for tiny bits of tumor DNA after colon cancer surgery. If found, it may help doctors catch any remaining cancer early and guide further treatment.
This study looks at a blood “DNA” test to see if it can help monitor colorectal cancer after surgery. It may benefit you by improving how doctors track cancer during routine follow-up visits.
This study is looking at whether regular checks of your blood for tiny pieces of cancer DNA (called MRD) can help doctors monitor for the cancer coming back after surgery. It plans to use this information to guide follow-up care.
This trial checks a stool test called FIT-DNA after colorectal (colon) cancer surgery. It aims to see whether this test can help doctors monitor for recurrence during follow-up and decide how closely to watch.
This trial uses a blood test (liquid biopsy) to look for tiny bits of cancer DNA remaining after surgery. It aims to see if this test can help guide follow-up and treatment decisions for people with colorectal cancer.
This study tests if a simple blood test can detect early signs of colorectal cancer coming back after surgery to remove cancer spread in the abdomen. It may help patients avoid unnecessary treatments and catch recurrence sooner.
Hear when a new Adenocarcinoma of the Rectum trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.